Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
- PMID: 32531536
- PMCID: PMC7834233
- DOI: 10.1016/j.mehy.2020.109975
Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Yanan Li Mengdie Wang Yifan Zhou Jiang Chang Ying Xian Ling Mao Candong Hong Shengcai Chen Yong Wang Hailing Wang Man Li Huijuan Jin Bo Hu Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study 10.2139/ssrn.3550025 https://www.ssrn.com/abstract=3550025. - PMC - PubMed
-
- Wichmann D, Sperhake J, Lütgehetmann M, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020; [Epub ahead of print 6 May 2020]. doi: https://doi.org/10.7326/M20-2003). - PMC - PubMed
-
- Antiplatelet Therapy Following Percutaneous Coronary Intervention in Patients Complicated by COVID-19: Implications From Clinical Features to Pathological Findings. Circulation 2020;Apr 16:[Epub ahead of print] https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.046988. - PubMed
-
- Paul Little Non-steroidal anti-inflammatory drugs and covid-19 m1185 10.1136/bmj.m1185 http://www.bmj.com/lookup/doi/10.1136/bmj.m1185. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical